Summary
Two patients with newly diagnosed insulin dependent diabetes mellitus were treated with human leukocyte interferon based on the hypothesis that the diabetes was induced by an active viral infection in the pancreatic islets and could be arrested. High peak levels of serum interferon were achieved (100–200 U/ml) with minimal systemic side effects. There was no sustained therapeutic benefit as measured by increased production of endogenous insulin, or of C-peptide, or by a lower requirement for exogenous insulin. Further trials with interferon treatment should be undertaken only if evidence of active viral infection (culture, antigen detection) can be associated with insulin dependent diabetes onset and these markers followed during treatment.
Article PDF
Similar content being viewed by others
References
Fleegler FM, Rogers KD, Drash A, Rosenbloom AL, Travis LB, Court JM (1979) Age, sex, and season of onset of juvenile diabetes in different geographic areas. Pediatrics 63: 374–379
Gamble DR, Kinsley ML, Fitzgerald MG, Bolton R, Taylor KW (1969) Viral antibodies in diabetes mellitus. Br Med J 3: 627–630
Gamble DR, Taylor KW (1969) Seasonal incidence of diabetes mellitus. Br Med J 3: 631–633
Gamble DR, Taylor KW, Cumming H (1973) Coxsackie viruses and diabetes mellitus. Br Med J 4: 260–262
Gunderson E (1927) Is diabetes of infectious origin? J Infect Dis 41: 197–202
Yoon JW, Austin M, Onodera T, Notkins AL (1979) Virus-induced diabetes mellitus: Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300: 1173–1179
Champsaur K, Dussaix E, Samolyk D, Fabre M, Bach CH, Assan R (1980) Diabetes and Coxsackie virus B5 infection. Lancet I: 251
Messaritakis J, Karabula C, Kattamis C, Matsaniotis N (1971) Diabetes following mumps in sibs. Arch Dis Child 46: 561–562
Forrest JM, Menser MA, Harley JD (1969) Diabetes mellitus and congenital rubella. Pediatrics 44: 445–447
Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC (1976) Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 295: 517–522
Merigan TC, Rand KH, Pollard RB, Abdallah PS, Jordan GW, Fried RP (1978) Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med 298: 981–987
Gonen B, Goldman J, Baldwin D, Goldberg RB, Ryan WG, Blix PM, Schanzlin D, Fritz KJ, Rubenstein AH (1979) Metabolic control in diabetic patients. Diabetes 28: 749–753
Cantell K, Hervonen S, Mogensen KE, et al (1975) Human leukocyte interferon: Production, purification and animal experiments. In: Waymouth C (ed) The production and use of interferon for the treatment and prevention of human virus infection. The Tissue Culture Association, Baltimore, pp 35–38
Merigan TC (1971) A plaque inhibition assay for human interferon employing human neonate skin fibroblast monolayers and bovine vesicular stomatitis virus. In: Bloom BR, Glade PR (eds) In vitro methods in cell-mediated immunity. Academic Press, New York, pp 489–499
Block MB, Makoi ME, Steiner DF, Rubenstein AH (1972) Circulating C-peptide immunoreactivity: Studies in normals and diabetic patients. Diabetes 21: 1013–1026
Neufeld M, Maclaren NK, Lezotte D, McLaughlin JV, Riley WJ, Silverstein J, Rosenbloom AL (1980) Islet cell antibodies in U. S. Caucasians and blacks with insulin requiring diabetes. Diabetes 29: 589–592
Riley WJ, Neufeld M, Maclaren NK (1980) Complement fixing islet cell antibodies. A separate species? Lancet I: 1133
Hierholzer JC, Farris WA (1974) Follow-up of children infected in a Coxsackie virus B-3 and B-4 outbreak: No evidence of diabetes mellitus. J Infect Dis 129: 741–746
Dippe SE, Miller M, Bennett PH, Maynard JE, Berquist KR (1975) Lack of causal association between Coxsackie B4 virus infection and diabetes. Lancet I: 1314–1317
Riley W, Maclaren N, Rand KH, Bejar RL (1980) Inherited autoimmunity versus Coxsackie B4 in diabetes. Diabetes 29: 53A
Cudworth AG, White GBB, Woodrow JC, Gamble DR, Lendrum R, Bloom A (1977) Aetiology of juvenile-onset diabetes. Lancet I: 385–388
Armstrong RW, Merigan TC (1971) Varicella-zoster virus: Interferon production and comparative interferon sensitivity in human cell lines. J Gen Virol 12: 53–54
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rand, K.H., Rosenbloom, A.L., Maclaren, N.K. et al. Human leukocyte interferon treatment of two children with insulin dependent diabetes. Diabetologia 21, 116–119 (1981). https://doi.org/10.1007/BF00251277
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00251277